Table 1 Demographic and clinical data of participants.

From: Protective role of anti-SARS-CoV-2 antibody responses against vital organ related long COVID symptoms

Characteristic

 

Long COVID (LC) (n = 62)

Non long COVID (nLC) (n = 75)

p

Sex

Male (n, %)

18 (29.03)

28 (37.33)

p = 0.36

Female (n, %)

44 (70.96)

47 (62.67)

Age (years)

Median (min.max)

41 (22–77)

38 (27–90)

p = 0.050

Days with symptoms

Median (min.max.)

15 (1–45)

12(1–42)

p = 0.012

Hospitalization

n (%)

10 (16.1)

9 (12)

p = 0.62

Hospitalization (days)

Median (min.max.)

5.5 (3–24)

9 (2–14)

p = 0.53

Individuals who needed Intensive Care

n (%)

1 (1.61)

3 (4)

NA

Individuals who needed Mechanical Ventilation

n (%)

1 (1.61)

0

NA

Presence of any self-reported comorbidity

23 (37.1)

30 (40)

p = 0.86

Number of acute phase symptoms

 ≥ 4

58 (93.5)

44 (58.7)

P < 0.001

 < 4

4 (6.5)

31 (41.3)